In a groundbreaking revelation that promises to reshape our understanding of gene regulation, scientists have decrypted the elusive structural dynamics of the RNA-induced silencing complex (RISC) assembly, highlighting a critical interplay between molecular chaperones and small RNA duplexes. This discovery, published in Nature in 2026 by Lee et al., lifts the veil on the precise mechanism by which Argonaute (AGO) proteins are matured and loaded with their RNA guides, a process fundamental to cellular defense and gene silencing pathways.
RISC is the molecular engine driving RNA silencing, a key mechanism by which cells regulate gene expression and defend against viral genomes. Central to RISC’s function is AGO, a protein that binds small RNA molecules—either microRNAs or small interfering RNAs—serving as guides to target and silence complementary messenger RNAs. However, the maturation and loading of AGO with RNA was until now understood only superficially due to the transient and complex nature of its assembly.
The study illuminates the pivotal role of the human AGO–HSP90–p23 complex, now termed the AGO maturation complex (AMC). The AMC emerges as a specialized chaperone machinery that maintains AGO in an RNA-free but poised conformation, ready to engage RNA duplexes for strand loading. This insight reshapes the previous conception of RNA loading as a passive binding event, instead revealing it as an actively chaperoned and complex-driven process.
By harnessing cryogenic electron microscopy (cryo-EM), the researchers captured the AMC at a moment of transformation where AGO exhibits a dramatic open architecture, far removed from its compact conformation in the fully assembled RISC. The AGO protein undergoes an extraordinary unfolding, with its N domain and RNA-binding module (comprising PAZ, MID, and PIWI domains) being separated and strategically anchored on opposite flanks of the HSP90 dimer. This conformational plasticity, tethered solely by the flexible L1 linker, creates an expanded positively charged cleft specifically tailored to accept RNA duplexes.
The molecular choreography orchestrated by the AMC illustrates a remarkable convergence of protein folding and RNA recognition. The AGO domains, usually snugly folded when bound to RNA in the mature RISC, become spatially segregated, suggesting that AGO folding is directly coupled with RNA duplex engagement. This mechanistic coupling suggests that the RNA duplex is more than a substrate; it is a chaperone-like cofactor critical to guiding AGO’s domain assembly and functional maturation.
Importantly, the study underscores the necessity of a 5′-terminal phosphate group on the small RNA duplex for meaningful AGO folding and maturation. Single-stranded RNA variants lacking this structure failed to induce the conformational changes required for AGO to reach its functional state. This specificity provides molecular insight into why duplexes—and not single strands—are preferentially loaded and establishes chemical features of small RNAs essential for tuning RNA interference efficiency.
The assembly of the RISC is fundamentally a co-translational and cooperative process steered by molecular chaperones HSP90 and its cochaperone p23. The precise role of these chaperones extends beyond ATP-dependent folding to stabilizing an AGO intermediate state that is receptive to RNA duplexes. Here, the AMC serves as a molecular crucible where protein and RNA intersect, enabling AGO to adopt an RNA-loading conformation that primes it for subsequent gene-silencing activity.
These findings provide profound implications for therapeutic design, particularly for small interfering RNAs (siRNAs) and microRNA mimics. By elucidating the structural prerequisites for AGO loading, including duplex geometry and chemical features like the 5′ phosphate, this work offers a template to engineer RNA molecules with optimized loading efficiency and silencing potential, a vital step toward improving RNA-based therapeutic agents.
Moreover, the discovery shines light on a broader biological principle: chaperone complexes, in concert with their client ligands, can guide large, multidomain protein folding and assembly. The AGO maturation pathway exemplifies how intricate protein conformational landscapes can be navigated in vivo, combining intrinsic folding with cooperative ligand stabilization—advancing our fundamental understanding of cellular proteostasis.
The study also opens new experimental avenues. The purified AGO maturation complex morphologically and functionally mimics the in vivo assembly intermediate, thus offering a valuable platform for dissecting RNA loading and AGO folding mechanisms. Researchers now have a molecular tool to probe various small RNA features and chemical modifications in vitro, accelerating the rational engineering of novel RNA therapeutics with desired stability, potency, and target specificity.
Beyond biomedical applications, these structural insights deepen our grasp of gene regulatory networks and antiviral immunity. By controlling the assembly and activation of RISC, the AMC acts as a master regulator dictating the precision and timing of gene silencing responses. This level of regulation is crucial under conditions requiring rapid shifts in gene expression or in response to invading nucleic acids.
This discovery marks a quantum leap in RNA biology, marrying structural biology with RNA-mediated regulation and chaperone biology. The distinct modularity and flexibility of AGO, mandated by its chaperone-coordinated maturation, exemplify nature’s sophisticated strategies for managing macromolecular machines and their dynamic interactions with ligands.
As researchers delve further into the molecular nuances of the AGO–HSP90 interplay, opportunities arise to target these pathways pharmacologically. Modulating AGO maturation or stability could become an innovative approach to controlling RNA interference pathways to treat cancer, viral infections, and genetic disorders, thus broadening the horizon of precision medicine.
In summary, this pioneering study not only elucidates how AGO proteins are sculpted by chaperones and RNA duplexes but also reveals fundamental principles governing protein-RNA assembly complexes. It lays the groundwork for transforming both basic science and clinical applications by unlocking the molecular secrets of RISC biogenesis.
Subject of Research: The molecular mechanism of RNA-induced silencing complex assembly and the role of molecular chaperones in Argonaute protein maturation.
Article Title: Structural basis for chaperone-guided assembly of RNA-induced silencing complex.
Article References:
Lee, YY., Jeong, M., Lee, H. et al. Structural basis for chaperone-guided assembly of RNA-induced silencing complex. Nature (2026). https://doi.org/10.1038/s41586-026-10640-2
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41586-026-10640-2
Keywords: RNA-induced silencing complex, Argonaute protein, HSP90 chaperone, RNA duplex loading, RNA silencing, RISC assembly, microRNA, small interfering RNA, protein folding, cryo-electron microscopy, chaperone-client interaction, RNA therapeutics
Tags: AGO maturation complex structureAGO–HSP90–p23 complex functionArgonaute protein maturationchaperone-mediated RNA silencingmicroRNA and siRNA guide loadingmolecular chaperones in RNA silencingRNA duplex loading mechanismRNA silencing and cellular defenseRNA silencing gene regulationRNA-induced gene expression controlRNA-induced silencing complex assemblystructural dynamics of RISC assembly
